Medlive Technology Co., Ltd. (MEDLIVE) reported no changes in its share capital structure for May 2026, according to the company’s latest monthly return filed with Hong Kong Exchanges and Clearing Limited.

Authorised and Issued Capital • Authorised share capital remained at 50.00 billion ordinary shares with a par value of USD 0.00001 each, equivalent to USD 0.50 million. • Issued shares (excluding treasury shares) were unchanged at 740.11 million, and the company held no treasury shares. Consequently, total issued share capital stayed flat month-on-month.

Public Float Status • MEDLIVE confirmed compliance with the Main Board’s public-float requirement. The minimum prescribed float at listing is 24.98 % of issued shares, a threshold the company continued to meet as at 31 May 2026.

Share Option Activity • Pre-IPO Share Option Scheme (adopted 29 March 2021): 160,375 options outstanding; no exercises or cancellations occurred. • Post-IPO Share Option Scheme (adopted 18 June 2021): no options outstanding, with capacity remaining for up to 69.02 million shares to be granted. • No share options were exercised during the month; therefore, no new shares were issued and no funds were raised through option exercises.

Other Equity Instruments • The company reported no warrants, convertibles, or other share-linked agreements outstanding or transacted during the month.

Overall, MEDLIVE’s equity structure remained static through May 2026, reflecting prudent capital management and ongoing adherence to Hong Kong listing requirements.